Axon Enterprise stock hits 52-week low at $291.45
Axon Enterprise Inc's shares have plummeted to a 52-week low of $291.45, marking a 56% decrease from its highest point in the same period of $665.07. The stock has seen a significant drop of 45.1% over the past year, despite the company's solid financial performance. Revenue has increased by 34% and gross profit margins stand at 57%, according to InvestingPro analysis, which suggests the stock is undervalued and among the top picks on the Most Undervalued stocks list.
While investors keep a close eye on Axon's recovery prospects, recent financial results have raised concerns. The company's third-quarter earnings failed to meet expectations, prompting several analysts to revise their price targets downward. Raymond James decreased its target price to $475, pointing to delays in federal Dedrone projects and margin pressures from their growing hardware business.
Northland and RBC Capital also lowered their price targets to $540 and $615 respectively, blaming procurement timing issues and election-cycle impacts on federal contracts. Piper Sandler followed suit, lowering its target to $540 after Axon's bookings and revenue fell 3% short of estimates. Needham took a similar stance, cutting its price target to $500 due to revenue falling below consensus expectations.
However, analysts still maintain a generally positive outlook, with most describing Axon as either Outperform or Buy . The delays in projects are seen as temporary setbacks rather than permanent failures, as any postponements are better than cancellations. This report, featuring AI-generated insights, was meticulously reviewed by an editor to ensure accuracy.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.